# Cough Desensitization Therapy for Cough Hypersensitivity Syndrome

> **NCT04256733** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Montana** · enrollment: 19 (actual)

## Conditions studied

- Cough

## Interventions

- **BIOLOGICAL:** Supra-threshold and progressive doses of diluted capsaicin via a Koko Digidoser nebulizer
- **BIOLOGICAL:** Sub-threshold doses of diluted capsiacin via a KoKo Digidoser nebulizer

## Key facts

- **NCT ID:** NCT04256733
- **Lead sponsor:** University of Montana
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-02-13
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04256733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04256733, "Cough Desensitization Therapy for Cough Hypersensitivity Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04256733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*